Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy

There is an urgent need to identify efficient antiviral compounds to combat existing and emerging RNA virus infections, particularly those related to seasonal and pandemic influenza outbreaks. While inhibitors of the influenza viral integral membrane proton channel protein (M2), neuraminidase (NA),...

Descripción completa

Detalles Bibliográficos
Autores principales: Marsili, Giulia, Acchioni, Chiara, Remoli, Anna Lisa, Amatore, Donatella, Sgarbanti, Rossella, De Angelis, Marta, Orsatti, Roberto, Acchioni, Marta, Astolfi, Andrea, Iraci, Nunzio, Puzelli, Simona, Facchini, Marzia, Perrotti, Edvige, Cecchetti, Violetta, Sabatini, Stefano, Superti, Fabiana, Agamennone, Mariangela, Barreca, Maria Letizia, Hiscott, John, Nencioni, Lucia, Sgarbanti, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341698/
https://www.ncbi.nlm.nih.gov/pubmed/37445672
http://dx.doi.org/10.3390/ijms241310495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341698/
https://www.ncbi.nlm.nih.gov/pubmed/37445672
http://dx.doi.org/10.3390/ijms241310495

Ejemplares similares